Angeles Investment Advisors LLC Cuts Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Angeles Investment Advisors LLC lowered its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 8.2% in the fourth quarter, Holdings Channel reports. The firm owned 456 shares of the medical equipment provider’s stock after selling 41 shares during the period. Angeles Investment Advisors LLC’s holdings in Intuitive Surgical were worth $238,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently bought and sold shares of ISRG. Atala Financial Inc purchased a new stake in Intuitive Surgical during the fourth quarter worth approximately $25,000. Berbice Capital Management LLC acquired a new position in shares of Intuitive Surgical during the 4th quarter valued at $26,000. BankPlus Trust Department purchased a new stake in Intuitive Surgical during the 4th quarter worth $28,000. Kohmann Bosshard Financial Services LLC acquired a new stake in Intuitive Surgical in the 4th quarter valued at $31,000. Finally, Decker Retirement Planning Inc. purchased a new position in Intuitive Surgical in the fourth quarter valued at about $36,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

Shares of NASDAQ:ISRG opened at $508.58 on Tuesday. The stock has a market cap of $181.15 billion, a price-to-earnings ratio of 79.34, a PEG ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00. The stock’s 50 day moving average price is $561.62 and its 200 day moving average price is $532.25.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on ISRG shares. Barclays upped their target price on Intuitive Surgical from $610.00 to $674.00 in a research report on Monday, January 27th. Morgan Stanley raised shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and increased their price objective for the company from $522.00 to $650.00 in a research report on Monday, December 2nd. JPMorgan Chase & Co. boosted their target price on shares of Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. UBS Group raised their price target on shares of Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a report on Monday, January 27th. Finally, Raymond James boosted their price objective on shares of Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a report on Friday, January 24th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have given a buy rating to the company. According to MarketBeat.com, Intuitive Surgical has an average rating of “Moderate Buy” and a consensus price target of $611.86.

Insider Activity at Intuitive Surgical

In related news, EVP Brian Edward Miller sold 8,900 shares of the firm’s stock in a transaction that occurred on Tuesday, March 11th. The shares were sold at an average price of $485.07, for a total transaction of $4,317,123.00. Following the completion of the sale, the executive vice president now directly owns 5,758 shares in the company, valued at approximately $2,793,033.06. This trade represents a 60.72 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CFO Jamie Samath sold 94 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total transaction of $53,684.34. Following the completion of the transaction, the chief financial officer now owns 2,630 shares in the company, valued at approximately $1,502,019.30. This trade represents a 3.45 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 33,754 shares of company stock valued at $17,691,621 over the last 90 days. 0.90% of the stock is currently owned by corporate insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.